GLGLENVIEW CAPITAL MANAGEMENT, LLC
Institutional investor · Portfolio as of Q2 2020
Top Holdings44 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
TENET HEALTHCARE CORP | 19.8M | $357.9M | 9.9% | $17.93 | +1.48% | 7 qtrssince 2018-Q4 | Increased 61 |
TAKEDA PHARMACEUTIC-SP ADR | 16.2M | $290.4M | 8.0% | $18.88 | -10.23% | 6 qtrssince 2019-Q1 | Decreased 0 |
BAUSCH HEALTH COS INC | 15.6M | $286.1M | 7.9% | $22.43 | -18.90% | 7 qtrssince 2018-Q4 | Decreased 0 |
THE CIGNA GROUP | 1.3M | $244.3M | 6.7% | $160.84 | +6.68% | 7 qtrssince 2018-Q4 | Decreased 0 |
HCA HOLDINGS INC | 2.2M | $209.4M | 5.8% | $119.49 | -23.06% | 7 qtrssince 2018-Q4 | Decreased 0 |
DXC TECHNOLOGY CO | 12M | $197.8M | 5.5% | $48.08 | -66.56% | 7 qtrssince 2018-Q4 | Increased 66 |
MCKESSON CORP | 1.2M | $187M | 5.2% | $105.01 | +39.58% | 7 qtrssince 2018-Q4 | Decreased 0 |
PARAMOUNT GLOBAL | 5.8M | $134.2M | 3.7% | — | — | 3 qtrssince 2019-Q4 | Decreased 0 |
NUANCE COMMUNICATIONS INC | 5M | $127.6M | 3.5% | — | — | 7 qtrssince 2018-Q4 | Decreased 0 |
| 734,044 | $121.9M | 3.4% | $4.10 | 0.00% | 1 qtr | New 84 | |
FMC CORP | 1.1M | $114.3M | 3.2% | $52.60 | +56.85% | 7 qtrssince 2018-Q4 | Decreased 0 |
HOLOGIC INC | 1.9M | $110.3M | 3.0% | $43.06 | +23.84% | 7 qtrssince 2018-Q4 | Decreased 0 |
MERITOR INC | 5.5M | $107.9M | 3.0% | — | — | 7 qtrssince 2018-Q4 | Decreased 0 |
AMERISOURCEBERGEN CORP | 955,159 | $96.3M | 2.7% | $71.04 | +21.90% | 7 qtrssince 2018-Q4 | Increased 65 |
IQVIA HOLDINGS INC | 551,258 | $78.2M | 2.2% | $115.32 | +19.25% | 7 qtrssince 2018-Q4 | Decreased 0 |
BOSTON SCIENTIFIC CORP | 2.1M | $74.2M | 2.0% | $31.64 | +9.51% | 2 qtrssince 2020-Q1 | Decreased 0 |
CORTEVA INC | 2.5M | $67.5M | 1.9% | $25.80 | -4.97% | 3 qtrssince 2019-Q4 | Increased 72 |
HUMANA INC | 171,332 | $66.4M | 1.8% | $252.45 | +43.10% | 7 qtrssince 2018-Q4 | Decreased 0 |
UNIVERSAL HEALTH SERVICES-B | 678,152 | $63M | 1.7% | $97.79 | -8.10% | 7 qtrssince 2018-Q4 | Increased 74 |
DAVITA INC | 787,483 | $62.3M | 1.7% | $77.21 | 0.00% | 1 qtr | New 68 |
GLENVIEW CAPITAL MANAGEMENT, LLC manages $3.6B across 44 positions as of Q2 2020. Top holdings: THC (9.9%), TAK (8.0%), BHC (7.9%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 4/5.0.
Active quarter - 10 new positions, 11 exits, 8 increased. Top move: UHS (INCREASED, conviction 74). Portfolio: $3.6B across 44 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer